| Product Code: ETC7554642 | Publication Date: Sep 2024 | Product Type: Market Research Report | ||
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The India sterile injectable drugs market import shipment witnessed a significant decline with a CAGR of -13.8% from 2020 to 2024. The growth rate between 2023 and 2024 showed a slight improvement but remained negative at -2.6%. The market exhibited a notable contraction, indicating a persistent downward trend with some signs of stabilization towards the end of the period.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Sterile Injectable Drugs Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Sterile Injectable Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 India Sterile Injectable Drugs Market - Industry Life Cycle |
3.4 India Sterile Injectable Drugs Market - Porter's Five Forces |
3.5 India Sterile Injectable Drugs Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
4 India Sterile Injectable Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases in India |
4.2.2 Growing demand for advanced healthcare facilities and treatments |
4.2.3 Rising geriatric population leading to higher healthcare needs |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for manufacturing and marketing sterile injectable drugs |
4.3.2 High costs associated with research, development, and production of sterile injectable drugs |
5 India Sterile Injectable Drugs Market Trends |
6 India Sterile Injectable Drugs Market, By Types |
6.1 India Sterile Injectable Drugs Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 India Sterile Injectable Drugs Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 India Sterile Injectable Drugs Market Revenues & Volume, By Monoclonal Antibodies (Mabs), 2021- 2031F |
6.1.4 India Sterile Injectable Drugs Market Revenues & Volume, By Cytokines, 2021- 2031F |
6.1.5 India Sterile Injectable Drugs Market Revenues & Volume, By Insulin, 2021- 2031F |
6.1.6 India Sterile Injectable Drugs Market Revenues & Volume, By Peptide Hormones, 2021- 2031F |
6.1.7 India Sterile Injectable Drugs Market Revenues & Volume, By Vaccine, 2021- 2031F |
6.1.8 India Sterile Injectable Drugs Market Revenues & Volume, By Immunoglobulins, 2021- 2031F |
6.1.9 India Sterile Injectable Drugs Market Revenues & Volume, By Peptide Antibodies, 2021- 2031F |
6.1.10 India Sterile Injectable Drugs Market Revenues & Volume, By Peptide Antibodies, 2021- 2031F |
7 India Sterile Injectable Drugs Market Import-Export Trade Statistics |
7.1 India Sterile Injectable Drugs Market Export to Major Countries |
7.2 India Sterile Injectable Drugs Market Imports from Major Countries |
8 India Sterile Injectable Drugs Market Key Performance Indicators |
8.1 Number of new product approvals by regulatory authorities |
8.2 Adoption rate of sterile injectable drugs in healthcare facilities |
8.3 Rate of investment in RD for sterile injectable drugs |
8.4 Percentage of hospitals and clinics equipped to handle sterile injectable drugs |
8.5 Number of partnerships and collaborations for the development and distribution of sterile injectable drugs |
9 India Sterile Injectable Drugs Market - Opportunity Assessment |
9.1 India Sterile Injectable Drugs Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
10 India Sterile Injectable Drugs Market - Competitive Landscape |
10.1 India Sterile Injectable Drugs Market Revenue Share, By Companies, 2024 |
10.2 India Sterile Injectable Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here